The work of the WHO Consultative Group on Poliomyelitis Vaccines
- PMID: 2840219
- PMCID: PMC2491049
The work of the WHO Consultative Group on Poliomyelitis Vaccines
Abstract
PIP: Through a review of the work on the control of poliomyelitis carried out under the auspices of the World Health Organization (WHO) during the past 20 years, the importance of international collaboration is shown. Because of efforts in planning and coordinating, the production and control of the Sabin strains of the live oral vaccine provide safe, reliable, and potent vaccines. The cooperative efforts have included working not only with national control laboratories but with poliomyelitis vaccine producers in many countries. In the early 1970s, a Consultative Group of WHO became active. Their initial efforts included an extensive epidemiological study in 13 interested countries. Later, the group saw to studying the reliability of the marker tests used in the intratypic differentiation of poliovirus stains of different origins. Additionally, they saw to standardizing tests for the neurovirulence of vaccine lots, including analyzing and recording results, and to ensuring that adequate supplies of vaccine will be available for the next 200 years. After 15 years of continual surveillance of vaccine-associated cases by WHO epidemiologists and clinicians, the findings show the following: Type 1 live poliovirus vaccine is almost never implicated in postvaccination paralysis; type 2 strain occasionally causes of paralysis in contacts of the vaccine, and type 3 strain causes most of the few cases of postvaccine paralysis. The occurrences of the cases from type 2 and 3 strains remains an enigma. Current research of the group suggests an even more effective vaccine may become available in the future.
Similar articles
-
The relation between acute persisting spinal paralysis and poliomyelitis vaccine (oral): results of a WHO enquiry.Bull World Health Organ. 1976;53(4):319-31. Bull World Health Organ. 1976. PMID: 1086727 Free PMC article.
-
Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.Dev Biol Stand. 1993;78:61-70. Dev Biol Stand. 1993. PMID: 8388832 Review.
-
Characterization of mutations in the VP(1) region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran.J Clin Virol. 2007 Aug;39(4):304-7. doi: 10.1016/j.jcv.2007.04.017. Epub 2007 Jun 21. J Clin Virol. 2007. PMID: 17590391
-
The relation between acute persisting spinal paralysis and poliomyelitis vaccine--results of a ten-year enquiry. WHO Consultative Group.Bull World Health Organ. 1982;60(2):231-42. Bull World Health Organ. 1982. PMID: 6980734 Free PMC article.
-
[End phase challenges of poliomyelitis eradication programme realization].Przegl Epidemiol. 2005;59(1):59-68. Przegl Epidemiol. 2005. PMID: 16013411 Review. Polish.
Cited by
-
Poliomyelitis: eradication in sight.Epidemiol Infect. 1992 Feb;108(1):1-18. doi: 10.1017/s0950268800049451. Epidemiol Infect. 1992. PMID: 1547830 Free PMC article. Review.
-
Mass polio vaccination.BMJ. 1996 May 11;312(7040):1178-9. doi: 10.1136/bmj.312.7040.1178. BMJ. 1996. PMID: 8634552 Free PMC article. No abstract available.
-
Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden.J Infect Dis. 2014 Nov 1;210 Suppl 1(Suppl 1):S380-9. doi: 10.1093/infdis/jiu184. J Infect Dis. 2014. PMID: 25316859 Free PMC article. Review.
-
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2. Cochrane Database Syst Rev. 2019. PMID: 31801180 Free PMC article.
-
Social, economic and psychological impacts of childhood diseases subject to immunization.Infection. 1991 Jul-Aug;19(4):237-41. doi: 10.1007/BF01644952. Infection. 1991. PMID: 1917035 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous